lipitor cough
† See Sections 5.1 and 7 for clinical significance. The reduction in the rate of CHF with hospitalization was only observed in the 8% of patients with a prior history of CHF. Lipitor can lower the risk for heart attack or stroke in patients with diabetes and risk factors such as: eye problems, kidney problems, smoking, or high blood pressure. Version: 12.01. Atherosclerosis is a chronic process and discontinuation of lipid-lowering drugs during pregnancy should have little impact on the outcome of long-term therapy of primary hypercholesterolemia. Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin lipitor cough drug and dosing regimen Atorvastatin Dose (mg) Change in AUC* Change in Cmax* †Cyclosporine 5.2 mg/kg/day, stable dose 10 mg QD for 28 days ↑ 8.7 fold ↑ 10.7 fold †Lopinavir 400 mg BID/ ritonavir 100 mg BID, 14 days 20 mg QD for 4 days ↑ 5.9 fold ↑ 4.7 fold †Ritonavir 400 mg BID/ saquinavir 400 mg BID, 15 days 40 mg QD for 4 days ↑ 3.9 fold ↑ 4.3 fold †Clarithromycin 500 mg BID, 9 days 80 mg lipitor cough for 8 days ↑ 4.4 fold ↑ 5.4 fold †Itraconazole 200 mg QD, 4 days 40 mg SD ↑ 3.3 lipitor cough ↑ 20% †Grapefruit Juice, 240 mL QD ‡ 40 mg SD ↑ 37% ↑ 16% Diltiazem 240 mg QD, 28 days 40 mg SD ↑ 51% No change Erythromycin 500 mg QID, 7 days 10 mg SD ↑ 33% ↑ 38% Amlodipine 10 mg, single dose 80 mg SD ↑ 15% ↓ 12% Cimetidine 300 mg QD, 4 weeks 10 mg QD for 2 weeks ↓ Less than 1% ↓ 11% Colestipol 10 mg BID, 28 weeks 40 mg QD for 28 weeks Not determined ↓ 26% § Maalox TC® 30 mL QD, 17 days 10 mg QD for 15 days ↓ 33% ↓ 34% Efavirenz 600 mg QD, 14 days 10 mg for 3 days ↓ 41% ↓ 1% †Rifampin 600 mg QD, 7 days lipitor cough ¶ 40 mg SD ↑ 30% ↑ 2.7 fold †Rifampin 600 mg QD, 5 days (dose separated) ¶ 40 mg lipitor cough ↓ 80% ↓ 40% †Gemfibrozil 600 mg BID, 7 days 40 mg SD ↑ 35% ↓ lipitor cough than 1% †Fenofibrate 160 mg QD, 7 days 40 mg SD ↑ 3% ↑ 2% * Data given as x-fold change represent a simple ratio between co-administration and atorvastatin alone (i.e., 1-fold = no change). Adverse Reaction* Any dose N=8755 10 mg N=3908 20 mg N=188 40 mg lipitor cough 80 mg N=4055 Placebo N=7311 * Adverse Reaction ≥ 2% in any dose greater than placebo Nasopharyngitis 8.3 12.9 5.3 7.0 4.2 8.2 Arthralgia 6.9 8.9 11.7 10.6 4.3 6.5 Diarrhea 6.8 7.3 6.4 14.1 5.2 6.3 Pain in extremity 6.0 8.5 3.7 9.3 3.1 5.9 Urinary tract infection 5.7 6.9 6.4 8.0 4.1 5.6 Dyspepsia 4.7 5.9 3.2 6.0 3.3 4.3 Nausea 4.0 3.7 3.7 7.1 3.8 3.5 Musculoskeletal pain 3.8 5.2 3.2 5.1 2.3 3.6 Muscle Spasms 3.6 4.6 4.8 5.1 2.4 3.0 Myalgia 3.5 3.6 5.9 8.4 2.7 3.1 Insomnia 3.0 2.8 1.1 5.3 2.8 2.9 Pharyngolaryngeal pain 2.3 3.9 1.6 2.8 0.7 2.1 Other adverse reactions reported in placebo-controlled studies include: Body as a whole: malaise, pyrexia; Digestive system: abdominal discomfort, eructation, flatulence, hepatitis, cholestasis; Musculoskeletal system: musculoskeletal pain, muscle fatigue, neck pain, joint swelling; Metabolic and nutritional system: transaminases increase, liver function test abnormal, blood alkaline phosphatase increase, creatine phosphokinase increase, hyperglycemia; Nervous system: nightmare; Respiratory system: epistaxis; Skin and appendages: urticaria; Special senses: vision blurred, tinnitus; Urogenital system: white blood cells urine positive. If the range does not include 0, this indicates a statistically significant difference. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Lipitor: Constipation; gas; headache; stomach pain or upset; weakness. Prescribing recommendations for interacting agents are summarized in Table 1 . In 89% lipitor cough these cases, drug treatment started before pregnancy and lipitor cough during the first trimester when pregnancy was identified. Do not breast-feed while you are taking Lipitor. In addition to diabetes, subjects had 1 or more of the following risk factors: current smoking (23%), hypertension (80%), retinopathy (30%), or microalbuminuria (9%) or macroalbuminuria (3%). In patients with Fredrickson Types IIa and IIb hyperlipoproteinemia pooled from 24 controlled trials, the median (25th and 75th percentile) percent changes from baseline in HDL-C for Lipitor 10, 20, 40, and 80 mg were 6.4 (-1.4, 14), 8.7 (0, 17), 7.8 (0, 16), and 5.1 (-2.7, 15), respectively. Continue to take Lipitor even if you feel well.
Online pharmacy Tags
215 216 217 218 219 220 221 222 223
.